Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol
-
Published:2024-09
Issue:
Volume:339
Page:116005
-
ISSN:0165-1781
-
Container-title:Psychiatry Research
-
language:en
-
Short-container-title:Psychiatry Research
Author:
Jieu Beverly,
Sykorova Eliska B.ORCID,
Rohleder CathrinORCID,
Marcolini Elisabeth,
Hoffmann Anna E.ORCID,
Koethe Dagmar,
Leweke F. MarkusORCID,
Couttas Timothy A.ORCID
Reference112 articles.
1. Targeting the endocannabinoid system: future therapeutic strategies;Aizpurua-Olaizola;Drug Discov. Today,2017
2. ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipids;Allwright;Sci. Rep.,2024
3. Blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients;Aquino;Front. Psychiatry,2018
4. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine;Artmann;Biochim. Biophys. Acta,2008
5. Cannabidiol interactions with medications, illicit substances, and alcohol: a comprehensive review;Balachandran;J. Gen. Intern. Med.,2021